Stock screener

AVNS

Conviction 88HealthcareScan · Thu, Jun 25, 2026
AVNS$24.91-0.16%
ResistanceSupportVol 14
63 bars
Vol MA14 1M
Mar 26Apr 14May 1May 19Jun 8Jun 25
AVANOS MEDICAL, INC.ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIESwww.avanos.com
Price24.91
Change-0.16%
Gap-0.08%
Rel volume1.42×
Avg volume1.31M
Avg $ vol32.74M
SMA 2024.95
SMA 5024.80
SMA 20015.61
Price vs 50+0.45%
Price vs 200+59.54%
MA stackbullish
50/200 cross
Supertrendup · 24.70
RSI (14)66
MACD hist-0.11
MACD cross
Stoch %K / %D17 / 26
ADX (14)60
+DI / −DI36 / 12
RSI divergence
MACD divergence
ATR %+0.48%
ADR %0.39%
52w high25.05
52w low9.89
From 52w high-0.56%
Above 52w low+151.87%
New 52w highNo
SqueezeOff
Bollinger width1.16%
%B0.36
Donchian pos21.62%
Donchian high25.49
Donchian low24.75
AVWAP (52w high)25.01
vs AVWAP high-0.39%
AVWAP (52w low)18.27
vs AVWAP low+36.34%
OBV trendFlat
Chaikin MF (20)-0.36
Today vs 20d1.42×
Avg vol (14d)1M
Avg vol (20d)1.31M
Avg $ vol (20d)32.74M
Market cap1.17B
RS 3m (vs SPY)+70.53%
RS 6m (vs SPY)+106.06%
RS line new highNo
Trend template8/8
Technical rank82.4
1 week+0.16%
1 month+0.65%
3 months+80.51%
6 months+117.55%
1 year+101.21%
YTD+122.81%
P/E-16.00
P/B1.49
P/S1.66
P/FCF27.06
EPS-1.57
Div yield
ROE-9.32%
ROA-6.94%
Debt/Eq0.30
Current2.48
EV/EBITDA-58.94
Gross margin50.47%
Net margin-10.40%
Rev growth1.95%
EPS growth81.41%
Price target
Target upside
Analyst rating
Institutional104.22%
Ent. value1.34B
Revenue182.2M
Net income5.1M
Gross profit94.2M
Free cash flow43.1M
IndustryORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES
ExchangeNYSE
Shares out46.85M
Employees2.29K
ListedTue, Oct 21, 2014
Free float44.5M
Float %95.7%
Short interest1.16M
Days to cover1.0d
Short volume54.6%
Squeeze score26 / 100
Next earningsTue, Aug 4, 2026 (40d)
EPS forecast$0.22 · 1 est
Last EPS vs est$0.22 vs $0.23
Last surprise-4.3% miss
Setup gradeA+
Conviction88 / 100
Pattern quality
Tech rank82.4 / 100
Group rank50 / 100
Status laneNo active setup
Setup direction
Pattern family
Resistance25.30
Support24.60
Days since event
Candle confirm
News sentiment

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in AVNS

All disclosures →
No recent disclosed trades by Congress in AVNS. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in AVNS · 5 buys · 3 sells

InsiderSideShares
Egbuonu-Davis Lisa
Director · Restricted Share Units · 2026-05-08
Grant12K
OLEARY PATRICK J
Director · Restricted Share Units · 2026-05-08
Grant12K
Shimer Julie Ann
Director · Restricted Share Units · 2026-05-08
Grant12K
BLACKFORD GARY
Director · Restricted Share Units · 2026-05-08
Grant12K
Franchini Indrani Lall
Director · Restricted Share Units · 2026-05-08
Grant12K
Delgado Sigfrido
SVP, Operations · Common Stock · 2026-04-22
Tax4.26K
Galovan Scott Michael
SVP, Chief Financial Officer · Common Stock · 2026-04-22
Tax4.23K
Pacitti David
Chief Executive Officer · Common Stock · 2026-04-14
Tax21.19K

SEC filings

EDGAR filings in AVNS · 1 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.